In response to the COVID-19 pandemic, cancer researchers are making changes to clinical trials to ensure patient safety and protect the integrity of their work. Some changes, such as greater use of telemedicine, will likely continue into the future.
This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892
No comments:
Post a Comment